TREATMENT OF OPIOID DEPENDENCE: APPROACHES AND PROSPECTS



Cite item

Full Text

Abstract

An overview of modern methods of opioid dependence treatment is presented. Main approaches to opioid detoxification as well as maintenance (anti-relapsing) therapy with comparative assessment of their efficacy are considered. A role of opioid receptor agonists and antagonists in the treatment system is analyzed. The supportive treatment with naltrexone is highlighted.

About the authors

Yury P Sivolap

The first Moscow state medical university, named after I.M. Sechenov

Email: yura-sivolap@yandex.ru
The first Moscow state medical university, named after I.M. Sechenov

References

  1. Блохина Е.А., Крупицкий Е.М., Брюн Е.А. Опыт применения Вивитрола (налтрексона пролонгированного действия в инъекциях) в клинической практике для лечения алкогольной зависимости // Обозрение психиатрии и медицинской психологии. - 2010. - № 3. - С. 58-62.
  2. Бохан Н.А., Семке В.Я. Коморбидность в наркологии. - Томск: Изд-во Томского университета, 2009. - 510 с.
  3. Дудко Т.Н., Сафина Н.Ф., Адамова Т.В., Абдрашитов Ш.Х. Использование Вивитрола при лечении и реабилитации больных алкоголизмом // Русский мед. Ж.. - 2010. - Т. 18 (6). - С. 1-7.
  4. Программа обеспечения доступа к контролируемым лекарственным средствам. Обеспечение сбалансированности национальной политики в отношении контролируемых веществ. Рекомендации по обеспечению наличия и доступности контролируемых лекарственных средств. - Женева, ВОЗ, 2011. - 100 с.
  5. Сиволап Ю.П., Савченков В.А. Злоупотребление опиоидами и опиоидная зависимость. - М.: Медицина, 2005. - 304 с.
  6. Сиволап Ю.П., Савченков В.А., Янушкевич М.В., Смирнова В.Н. Налтрексон-депо (вивитрол) в лечении алкоголизма: первый опыт применения в России // Наркология. -2009. - № 9. - С. 53-57.
  7. Basu D., Kumar V. Buprenorphine implants and opioid dependence // JAMA. -2011. - Vol. 305 (3). - P. 253-254.
  8. Bell J., Dru A., Fischer B. et al. Substitution therapy for heroin addiction // Subst. Use. Misuse. - 2002. - Vol. 37 (8-10). - P. 1149-1178.
  9. Benich J.J. 3rd. Opioid dependence // Prim. Care. - 2011. - Vol. 38 (1). - P. 59-70.
  10. Chang G., Kosten T.R. Detoxification. In.: Substance Abuse: A Comprehensive Textbook (4th ed.). - New York, Lippincott Williams & Wilkins, 2005. - P. 579-587.
  11. Cheskin L.J., Fudala P.J., Johnson R.E. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids // Drug. Alcohol. Depend. - Vol. 36. - P. 115-121.
  12. Ciraulo D.A., Dong Q., Silverman B.L. et al. Early treatment response in alcohol dependence with extended-release naltrexone // J. Clin. Psychiatry. - 2008. - Vol. 69 (2). - P. 190-195.
  13. Day E., Strang J. Outpatient versus inpatient opioid detoxification: a randomized controlled trial // J. Subst. Abuse. Treat. - 2011. - Vol. 40 (1). - P. 56-66.
  14. Esmaeili A., Keinhorst A.K., Schuster T. et al. Treatment of neonatal abstinence syndrome with clonidine and chloral hydrate // Acta. Paediatr. - 2010. - Vol. 99 (2). - P. 209-214.
  15. Everly J.J., Defulio A., Koffarnus M.N. et al. Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial. - Addiction, 2011 [Epub ahead of print].
  16. Ferri M., Davoli M., Perucci C.A. Heroin maintenance for chronic heroin-dependent individuals // Cochrane. Database. Syst. Rev. - 2010. - Vol. 8. - CD003410.
  17. Fiellin D.A., O'Connor P.G., Chawarski M. et al. Methadone maintenance in primary care: a randomized controlled trial // JAMA. - 2001. - Vol. 286 (14). - P. 1724-1731.
  18. Fishman M.J., Winstanley E.L., Curran E. et al. Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility // Addiction. - 2010. - Vol. 105 (9). - P. 1669-1676.
  19. Garbutt J.C. The state of pharmacotherapy for the treatment of alcohol dependence // J. Subst. Abuse. Treat. - 2009. - Vol. 36 (1). - S. 15-23.
  20. Garbutt J.C., Kranzler H.R., O'Malley S.S. et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence. A randomized controlled trial // JAMA. - 2005. - Vol. 293 (13). - P. 1617-1625.
  21. Gastfriend D.R. Intramuscular extended-release naltrexone: current evidence // Ann. N-Y. Acad. Sci. - 2011. - Vol. 1216. - P. 144-1466.
  22. Gish E.C., Miller J.L., Honey B.L., Johnson P.N. Lofexidine, an alpha-2-receptor agonist for opioid detoxification // Ann. Pharmacother. - 2010. - Vol. 44 (2). - P.343-351.
  23. Gowing L., Ali R., White J.M. Opioid antagonists with minimal sedation for opioid withdrawal // Cochrane. Database. Syst. Rev. - 2009. - Vol. 4. - CD002021.
  24. Gowing L., Ali R., White J.M. Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal // Cochrane. Database. Syst. Rev. - 2010. - Vol. 1. - CD002022.
  25. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. - Geneva, World Health Organisation, 2009. - 110 p.
  26. Kosten T.R., Krystal J.H., Charney D.S. et al. Rapid detoxification from opioid dependence // Am. J. Psychiatry. - 1989. - Vol. 147. - P. 1349-1349.
  27. Kosten T.R., O'Connor P.G. Management of drug and alcohol withdrawal // N. Engl. J. Med. - 2003. - Vol. 348. - P. 1786-1795.
  28. Krupitsky E., Nunes E.V., Ling W. et al. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial // Lancet. - 2011. - Vol. 377. - P. 1506-1513.
  29. Lee J.D., Grossman E., DiRocco D. et al. Extended-release naltrexone for treatment of alcohol dependence in primary care // J. Subst. Abuse. Treat. - 2010. - Vol. 39 (1). - P. 14-21.
  30. Lobmaier P., Gossop M., Waal H., Bramness J. The pharmacological treatment of opioid addiction - a clinical perspective // Eur. J. Clin. Pharmacol. - 2010. - Vol. 66 (6). - P. 537-545.
  31. Lucey M.R., Silverman B.L., Illeperuma A. et al. Hepatic safety of once-monthly injectable extended-release naltrexone administered to actively drinking alcoholics // Alcohol. Clin. Exp. Res. - 2008. - Vol. 32 (3). - P. 498-504.
  32. Maddux J.F., Desmond D.P. Methadone maintenance and recovery from opioid dependence // Am. J. Drug. Alcohol. Abuse. - 1992. - Vol. 18 (1). - Vol. 63-74.
  33. Mark T.L., Montejano L.B., Kranzler H.R. et al. Comparison of healthcare utilization among patients treated with alcoholism medications // Am. J. Manag. Care. - 2010. - Vol. 16 (12). - P. 879-888.
  34. McGivern J.G. Ziconotide: a review of its pharmacology and use in the treatment of pain // Neuropsychiatr. Dis. Treat. - 2007. - Vol. 3 (1). - P. 69-85.
  35. Metzger D.S., Woody G.E., O'Brien C.P. Drug treatment as HIV prevention: a research update // J. Acquir. Immune. Defic-Syndr. - 2010. - Vol. 55, Suppl 1. - S. 32-36.
  36. Minozzi S., Amato L., Davoli M. Detoxification treatments for opiate dependent adolescents // Cochrane. Database. Syst. Rev. - 2009. - Vol. 2. - CD006749.
  37. Minozzi S., Amato L., Vecchi S. et al. Oral naltrexone maintenance treatment for opioid dependence // Cochrane. Database. Syst. Rev. - 2011. - Vol. 2. - CD001333.
  38. Naderi-Heiden A., Naderi A., Naderi M.M. et al. Ultra-rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran // Pharmacopsychiatry. - 2010. - Vol. 43 (4). - P. 130-137.
  39. O'Brien C.P., Gastfriend D.R., Forman R.F. et al. Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone // Am. J. Addict. - 2011. - Vol. 20 (2). - P. 106-112.
  40. Ockert D., Volpicelli, J., Baier A.R. Jr. et al. A non-opioid procedure for outpatient opioid detoxification // Journal-Addiction-Med, Post Editor Corrections, 29 July 2010; doi: 10.1097/ADM.0b013e3181e518cc.
  41. O'Connor P.G., Samet J.H., Stein M.D. Management of hospitalized intravenous drug users: role of the internist // Am. J. Med. - 1994. - Vol. 96. - P. 551-558.
  42. O'Connor P.G., Waugh M.E., Carroll K.M. et al. Primary care-based ambulatory opioid detoxification: the results of a clinical trial // J. Gen. Intern. Med. - 1995. - Vol. 10. - P. 255-260.
  43. O'Malley S.S., Garbutt J.C., Gastfriend D.R. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment // J. Clin. Psychopharmacol. - 2007. - Vol. 27. - P. 507-512.
  44. Preston K.L., Bigelow G.E. Pharmacological advances in addiction treatment // Int. J. Addict. - 1985. - Vol. 20 (6-7). - P. 845-867.
  45. Raffaeli W., Righetti D., Sarti D. et al. Ziconotide: a rapid detoxification protocol for the conversion from intrathecal morphine - the Raffaeli Detoxification Model // J. Opioid. Manag. - 2011, Jan-Feb. - Vol. 7(1). - Р. 21-26.
  46. Shand F.L., Slade T., Degenhardt L. et al. Opioid dependence latent structure: two classes with differing severity? // Addiction. - 2011. - Vol. 106 (3). - P. 590-598.
  47. Stotts A.L., Dodrill C.L., Kosten T.R. Opioid dependence treatment: options in pharmacotherapy // Expert. Opin. Pharmacother. - 2009. - Vol. 10 (11). - P. 1727-1140.
  48. Strang J., Bearn J., Gossop M. Lofexidine for opiate detoxification: review of recent randomised and open controlled trials // Am. J. Addict. - 1999. - Vol. 8. - P. 337-348.
  49. Strang J., Metrebian N., Lintzeris N. et al. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial // Lancet. - 2010. - Vol. 375 (9729). - P. 1885-1895.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Sivolap Y.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 75562 от 12 апреля 2019 года.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies